Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

9.87
+0.51005.45%
Post-market: 9.980.1100+1.11%19:18 EDT
Volume:19.66M
Turnover:191.23M
Market Cap:4.47B
PE:-13.98
High:9.93
Open:9.45
Low:9.44
Close:9.36
52wk High:9.93
52wk Low:1.76
Shares:452.97M
Float Shares:394.00M
Volume Ratio:1.47
T/O Rate:4.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7058
EPS(LYR):-1.0941
ROE:-40.36%
ROA:-20.31%
PB:6.07
PE(LYR):-9.02

Loading ...

Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 19, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 29, 2024

Major Issues Report

Form 8-K - Current report